Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

A picorna-like virus suppresses the N-end rule pathway to inhibit apoptosis.

Wang Z, Xia X, Yang X, Zhang X, Liu Y, Wu D, Fang Y, Liu Y, Xu J, Qiu Y, Zhou X.

Elife. 2017 Dec 12;6. pii: e30590. doi: 10.7554/eLife.30590.

2.

Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition.

Mazurkiewicz M, Hillert EK, Wang X, Pellegrini P, Olofsson MH, Selvaraju K, D'Arcy P, Linder S.

Oncotarget. 2017 Mar 28;8(13):21115-21127. doi: 10.18632/oncotarget.15501.

3.

The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance.

Biswas K, Sarkar S, Du K, Brautigan DL, Abbas T, Larner JM.

Mol Cancer Res. 2017 Jun;15(6):651-659. doi: 10.1158/1541-7786.MCR-16-0466. Epub 2017 Feb 23.

PMID:
28232384
4.

The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.

Li Y, Huang J, Sun J, Xiang S, Yang D, Ying X, Lu M, Li H, Ren G.

Oncotarget. 2017 Jan 17;8(3):4501-4519. doi: 10.18632/oncotarget.13885.

5.

Tuning the proteasome to brighten the end of the journey.

Mayor T, Sharon M, Glickman MH.

Am J Physiol Cell Physiol. 2016 Nov 1;311(5):C793-C804. doi: 10.1152/ajpcell.00198.2016. Epub 2016 Sep 7. Review.

6.

Atypical role of sprouty in p21 dependent inhibition of cell proliferation in colorectal cancer.

Zhang Q, Shim K, Wright K, Jurkevich A, Khare S.

Mol Carcinog. 2016 Sep;55(9):1355-68. doi: 10.1002/mc.22379. Epub 2015 Aug 21.

7.

Anticancer Effect of a Novel Proteasome Inhibitor, YSY01A, via G2/M Arrest in PC-3M Cells in vitro and in vivo.

Zhang M, Yuan X, Xu B, Guo W, Ran FX, Li RT, Cui JR.

J Cancer. 2015 Jun 11;6(8):701-8. doi: 10.7150/jca.11785. eCollection 2015.

8.

Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.

Zhou X, Hao Q, Zhang Q, Liao JM, Ke JW, Liao P, Cao B, Lu H.

Cell Death Differ. 2015 May;22(5):755-66. doi: 10.1038/cdd.2014.167. Epub 2014 Oct 10.

9.

Glatiramer acetate and nanny proteins restrict access of the multiple sclerosis autoantigen myelin basic protein to the 26S proteasome.

Kuzina E, Kudriaeva A, Smirnov I, Dubina MV, Gabibov A, Belogurov A Jr.

Biomed Res Int. 2014;2014:926394. doi: 10.1155/2014/926394. Epub 2014 Sep 8.

10.

Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states.

Overton KW, Spencer SL, Noderer WL, Meyer T, Wang CL.

Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4386-93. doi: 10.1073/pnas.1409797111. Epub 2014 Sep 29.

11.

Regulating the 20S proteasome ubiquitin-independent degradation pathway.

Ben-Nissan G, Sharon M.

Biomolecules. 2014 Sep 23;4(3):862-84. doi: 10.3390/biom4030862. Review.

12.

Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23.

Blount JR, Tsou WL, Ristic G, Burr AA, Ouyang M, Galante H, Scaglione KM, Todi SV.

Nat Commun. 2014 Aug 21;5:4638. doi: 10.1038/ncomms5638.

13.

Timely activation of budding yeast APCCdh1 involves degradation of its inhibitor, Acm1, by an unconventional proteolytic mechanism.

Melesse M, Choi E, Hall H, Walsh MJ, Geer MA, Hall MC.

PLoS One. 2014 Jul 29;9(7):e103517. doi: 10.1371/journal.pone.0103517. eCollection 2014.

14.

Cables1 controls p21/Cip1 protein stability by antagonizing proteasome subunit alpha type 3.

Shi Z, Li Z, Li ZJ, Cheng K, Du Y, Fu H, Khuri FR.

Oncogene. 2015 May 7;34(19):2538-45. doi: 10.1038/onc.2014.171. Epub 2014 Jun 30.

15.

RNAP II CTD tyrosine 1 performs diverse functions in vertebrate cells.

Hsin JP, Li W, Hoque M, Tian B, Manley JL.

Elife. 2014 May 8;3:e02112. doi: 10.7554/eLife.02112.

16.

Multiple sclerosis autoantigen myelin basic protein escapes control by ubiquitination during proteasomal degradation.

Belogurov A Jr, Kudriaeva A, Kuzina E, Smirnov I, Bobik T, Ponomarenko N, Kravtsova-Ivantsiv Y, Ciechanover A, Gabibov A.

J Biol Chem. 2014 Jun 20;289(25):17758-66. doi: 10.1074/jbc.M113.544247. Epub 2014 Apr 16.

17.

Roles of the two distinct proteasome pathways in hepatitis C virus infection.

Shoji I.

World J Virol. 2012 Apr 12;1(2):44-50. doi: 10.5501/wjv.v1.i2.44.

18.

Structural disorder and the loss of RNA homeostasis in aging and neurodegenerative disease.

Gray DA, Woulfe J.

Front Genet. 2013 Aug 14;4:149. doi: 10.3389/fgene.2013.00149. eCollection 2013.

19.

The C-terminal residues of Saccharomyces cerevisiae Mec1 are required for its localization, stability, and function.

DaSilva LF, Pillon S, Genereaux J, Davey MJ, Gloor GB, Karagiannis J, Brandl CJ.

G3 (Bethesda). 2013 Oct 3;3(10):1661-74. doi: 10.1534/g3.113.006841.

20.

Fates of retroviral core components during unrestricted and TRIM5-restricted infection.

Kutluay SB, Perez-Caballero D, Bieniasz PD.

PLoS Pathog. 2013 Mar;9(3):e1003214. doi: 10.1371/journal.ppat.1003214. Epub 2013 Mar 7.

Supplemental Content

Support Center